article_metadata: Eduardo J Medina Youssef M Zohdy Edoardo Porto Juan M Revuelta Barbero David Bray Justin Maldonado Alejandra Rodas Miguel Mayol Bryan Morales Stewart Neill William Read Gustavo Pradilla Adriana Ioachimescu Tomas Garzon-Muvdi
article_metadata: 10.3389/fendo.2023.1195792
article_metadata: Front Endocrinol (Lausanne)
article_metadata: 2023 Jul 17;14:1195792.
article_metadata: aggressive atypical molecular biomarkers pazopanib prolactinoma pituitary adenomas
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/37529607/
article_metadata: Pituitary Neoplasms / drug therapy Pituitary Neoplasms / genetics Pituitary Neoplasms / metabolism Prolactinoma / drug therapy Prolactinoma / genetics Prolactinoma / metabolism
article_metadata: Pituitary Neoplasms / drug therapy Pituitary Neoplasms / genetics Pituitary Neoplasms / metabolism Prolactinoma / drug therapy Prolactinoma / genetics Prolactinoma / metabolism Case Reports Review Humans Indazoles / therapeutic use Male Middle Aged POU Domain Factors pazopanib 1-hexadecyl-2-acetyl-glycero-3-phosphocholine Indazoles POU6F2 protein, human POU Domain Factors
article_metadata: PMC10388536
article_metadata: 37529607
article_metadata: Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas
article_metadata: 2023